Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Sixty-five new genetic risk markers for breast cancer discovered

No. 51 | 23/10/2017 | by Koh

Until now, familial breast cancer has only partly been linkable to genetic risk markers. In a worldwide joint effort, researchers have now identified further genetic variants that affect the risk for breast cancer. The study, which was conducted with participation of researchers from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, has now been published in Nature. Scientists expect that the results will lead to improved screening, earlier detection and better treatments for this disease.

© Lutz Langbein, DKFZ

Ever since the wide media attention for Angelina Jolie's decision to have her breasts removed preventively, the genetic background of breast cancer has more or less been general knowledge. Mutations in the "breast cancer genes" BRCA1 and BRCA2 dramatically increase* the risk for breast cancer. However, they are very rare and account only for a small portion of breast cancer cases.

"However, there is a multitude of further genetic variations, each of which on its own has only little impact on the breast cancer risk," said Hermann Brenner from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg. "But altogether, they can be used to assess the breast cancer risk and, thus, also contribute to better prevention." Epidemiologist Brenner is one of the authors of the present study, which is the largest one worldwide on the genetic causes of breast cancer. Sixty-five further genetic risk markers were identified in the project that was coordinated by researchers from Cambridge and Harvard.

The familial breast cancer risk of women with first-degree relatives who have had breast cancer is about twice as high compared to the general population. The 65 newly identified risk markers are responsible for about four percent of this familial risk. Together with the about 100 genetic risk markers that are already known, an estimated 18 percent can be accounted for.

"In order to be able to predict each woman's individual breast cancer risk more accurately in the future, we want to include these genetic markers in model calculations, together with known risk factors," said DKFZ's Jenny Chang-Claude, who also collaborates in the study. "For example, the genetic risk factors that are known today already make it possible to identify women with an unfavorable risk profile; their risk of developing breast cancer is three and a half times higher than in the general population. Breast cancer screening programs and prevention measures can be individually adjusted based on these risk profiles."

It was a study of superlatives: It included DNA analyses of 256,000 women in total; about half of them suffered from breast cancer. About 90 percent of the participants were from Europe, the U.S.A. and Australia, and about 10 percent from Southeast Asia.

The investigators examined 11.8 million minute genetic variations in search for a possible link with the risk of developing breast cancer. These variants, which differ from each other only in a single DNA building block, are called single nucleotide polymorphisms, or SNPs. Based on the distribution of suspicious SNPs, the researchers were able to identify 65 DNA regions that are very likely to contribute to the breast cancer risk.

Studies of this scale are necessary in order to facilitate statistically ascertained statements about the individual SNPs. Until now, prior studies have focused chiefly on genetic variants that have a minimum prevalence in the population while usually showing only weak links to the breast cancer risk. Further studies will investigate more genetic variations that are less common but are associated with a higher disease risk. This also requires very large numbers of participants that can only be achieved in large international networks. The majority of the 65 newly discovered genetic risk markers are not located in the protein-coding regions of DNA but in so-called regulatory elements: These are genomic segments that are involved in the regulation of genes that can be located at some distance from them. Using computer simulations, the researchers discovered that most of these regulatory elements control cellular processes that are already known to be linked to the development of breast cancer.

*Experts estimate that in Germany approximately 65-75% of women with BRCA1 mutation and 45-65% of women with BRCA2 mutation will develop breast cancer before the age of 70 years.

Kyriaki Michailidou et al: Association analysis identifies 65 new breast cancer risk loci. Nature 2017, DOI: 10.1038/nature24284

A picture is available for download www.dkfz.de/de/presse/pressemitteilungen/2017/bilder/Brustkrebszellen.jpg

Note on use of images related to press releases
Use is free of charge. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) permits one-time use in the context of reporting about the topic covered in the press release. Images have to be cited as follows: "Source: Lutz Langbein, DKFZ".
Distribution of images to third parties is not permitted unless prior consent has been obtained from DKFZ's Press Office (phone: ++49-(0)6221 42 2854, E-mail: presse@dkfz.de). Any commercial use is prohibited.

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS